1
|
Laezza M, Pisapia L, Toro B, Mercadante V, Rispo A, Gianfrani C, Del Pozzo G. Changes upon the gluten-free diet of HLA-DQ2 and TRAFD1 gene expression in peripheral blood of celiac disease patients. J Transl Autoimmun 2024; 8:100240. [PMID: 38694231 PMCID: PMC11060953 DOI: 10.1016/j.jtauto.2024.100240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 03/26/2024] [Accepted: 03/28/2024] [Indexed: 05/04/2024] Open
Abstract
Background Celiac disease (CD) is a chronic immuno-mediated enteropathy caused by dietary gluten in genetically susceptible individuals carrying HLA (Human Leukocytes Antigen) genes that encode for DQ2.5 and DQ8 molecules. TRAFD1 (TRAF-type zinc finger domain 1) is a gene recently found associated with CD and defined as a master regulator of IFNγ signalling and of MHC class I antigen processing/presentation. There is no specific drug therapy and the only effective treatment is the gluten-free diet (GFD). The great majority of celiac patients when compliant with GFD have a complete remission of symptoms and recovery of gut mucosa architecture and function. Until now, very few studies have investigated molecular differences occurring in CD patients upon the GFD therapy. Methods We looked at the expression of both HLA DQ2.5 and TRAFD1 risk genes in adult patients with acute CD at the time of and in treated patients on GFD. Specifically, we measured by qPCR the HLA-DQ2.5 and TRAFD1 mRNAs on peripheral blood mononuclear cells (PBMC) from the two groups of patients. Results When we compared the HLA-DQ mRNA expression, we didn't find significant variation between the two groups of patients, thus indicating that GFD patients have the same capability to present gliadin antigens to cognate T cells as patients with active disease. Conversely, TRAFD1 was more expressed in PBMC from treated CD subjects. Notably, TRAFD1 transcripts significantly increased in the patients analyzed longitudinally during the GFD, indicating a role in the downregulation of gluten-induced inflammatory pathways. Conclusion Our study demonstrated that HLA-DQ2.5 and TRAFD1 molecules are two important mediators of anti-gluten immune response and inflammatory process.
Collapse
Affiliation(s)
- Mariavittoria Laezza
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, National Research Council, Naples, Italy
| | - Laura Pisapia
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, National Research Council, Naples, Italy
| | - Benedetta Toro
- Gastroenterology, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
| | - Vincenzo Mercadante
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, National Research Council, Naples, Italy
| | - Antonio Rispo
- Gastroenterology, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
| | - Carmen Gianfrani
- Institute of Biochemistry and Cell Biology, National Research Council, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, National Research Council, Naples, Italy
| |
Collapse
|
2
|
Del Mastro A, Picascia S, D'Apice L, Trovato M, Barba P, Di Biase I, Di Biase S, Laccetti M, Belli A, Amato G, Di Muro P, Credendino O, Picardi A, De Berardinis P, Del Pozzo G, Gianfrani C. Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant. Viruses 2023; 15:v15051132. [PMID: 37243218 DOI: 10.3390/v15051132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 04/29/2023] [Accepted: 05/08/2023] [Indexed: 05/28/2023] Open
Abstract
Kidney transplanted recipients (KTR) are at high risk of severe SARS-CoV-2 infection due to immunosuppressive therapy. Although several studies reported antibody production in KTR after vaccination, data related to immunity to the Omicron (B.1.1.529) variant are sparse. Herein, we analyzed anti-SARS-CoV-2 immune response in seven KTR and eight healthy controls after the second and third dose of the mRNA vaccine (BNT162b2). A significant increase in neutralizing antibody (nAb) titers were detected against pseudoviruses expressing the Wuhan-Hu-1 spike (S) protein after the third dose in both groups, although nAbs in KTR were lower than controls. nAbs against pseudoviruses expressing the Omicron S protein were low in both groups, with no increase after the 3rd dose in KTR. Reactivity of CD4+ T cells after boosting was observed when cells were challenged with Wuhan-Hu-1 S peptides, while Omicron S peptides were less effective in both groups. IFN-γ production was detected in KTR in response to ancestral S peptides, confirming antigen-specific T cell activation. Our study demonstrates that the 3rd mRNA dose induces T cell response against Wuhan-Hu-1 spike peptides in KTR, and an increment in the humoral immunity. Instead, humoral and cellular immunity to Omicron variant immunogenic peptides were low in both KTR and healthy vaccinated subjects.
Collapse
Affiliation(s)
- Andrea Del Mastro
- AORN A. Cardarelli-Internal Medicine Division 1-Immunology Unit, 80131 Naples, Italy
| | - Stefania Picascia
- Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy
| | - Luciana D'Apice
- Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy
| | - Maria Trovato
- Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy
| | - Pasquale Barba
- Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy
| | | | | | - Marco Laccetti
- AORN A. Cardarelli-Internal Medicine Division 1-Immunology Unit, 80131 Naples, Italy
| | - Antonello Belli
- AORN A. Cardarelli-Clinical Pathology Division, 80131 Naples, Italy
| | - Gerardino Amato
- AORN A. Cardarelli-Clinical Pathology Division, 80131 Naples, Italy
| | - Potito Di Muro
- AORN A. Cardarelli-Nephrology and Dialysis Unit, 80131 Naples, Italy
| | - Olga Credendino
- AORN A. Cardarelli-Nephrology and Dialysis Unit, 80131 Naples, Italy
| | - Alessandra Picardi
- AORN A. Cardarelli-Molecular Biology Laboratory-Hematology and HSC Transplantation Unit, 80131 Naples, Italy
| | | | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics, Italian National Council of Research, 80131 Naples, Italy
| | - Carmen Gianfrani
- Institute of Biochemistry and Cell Biology, Italian National Council of Research, 80131 Naples, Italy
| |
Collapse
|
3
|
Marranci A, Prantera A, Masotti S, De Paolo R, Baldanzi C, Podda MS, Mero S, Vitiello M, Franchin C, Laezza M, Comelli L, Arrigoni G, Cervelli T, Del Pozzo G, Poliseno L. PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation. J Hematol Oncol 2023; 16:33. [PMID: 37013641 PMCID: PMC10071733 DOI: 10.1186/s13045-023-01428-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Accepted: 03/17/2023] [Indexed: 04/05/2023] Open
Abstract
In human cells BRAF oncogene is invariably expressed as a mix of two coding transcripts: BRAF-ref and BRAF-X1. These two mRNA isoforms, remarkably different in the sequence and length of their 3'UTRs, are potentially involved in distinct post-transcriptional regulatory circuits. Herein, we identify PARP1 among the mRNA Binding Proteins that specifically target the X1 3'UTR in melanoma cells. Mechanistically, PARP1 Zinc Finger domain down-regulates BRAF expression at the translational level. As a consequence, it exerts a negative impact on MAPK pathway, and sensitizes melanoma cells to BRAF and MEK inhibitors, both in vitro and in vivo. In summary, our study unveils PARP1 as a negative regulator of the highly oncogenic MAPK pathway in melanoma, through the modulation of BRAF-X1 expression.
Collapse
Affiliation(s)
- Andrea Marranci
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy.
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy.
- Fondazione Pisana per la Scienza ONLUS, 56017, Pisa, Italy.
| | - Antonella Prantera
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- University of Siena, Siena, Italy
| | - Simona Masotti
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
| | - Raffaella De Paolo
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- University of Siena, Siena, Italy
| | - Caterina Baldanzi
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- University of Siena, Siena, Italy
| | - Maurizio S Podda
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- University of Siena, Siena, Italy
| | - Serena Mero
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- Molecular Medicine and Neurobiology, IRCCS Fondazione Stella Maris, 56128, Pisa, Italy
| | - Marianna Vitiello
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy
- Genetics, Department of Biology, University of Pisa, 56126, Pisa, Italy
| | - Cinzia Franchin
- Department of Biomedical Sciences, University of Padova, Padua, Italy
- Proteomics Center, University of Padova and Azienda Ospedaliera di Padova, Padua, Italy
| | - Mariavittoria Laezza
- Institute of Genetics and Biophysics "Adriano Buzzati Traverso", CNR, Naples, Italy
| | - Laura Comelli
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
| | - Giorgio Arrigoni
- Department of Biomedical Sciences, University of Padova, Padua, Italy
- Proteomics Center, University of Padova and Azienda Ospedaliera di Padova, Padua, Italy
| | - Tiziana Cervelli
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics "Adriano Buzzati Traverso", CNR, Naples, Italy
| | - Laura Poliseno
- Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124, Pisa, Italy.
- Oncogenomics Unit, Core Research Laboratory, ISPRO, Via Moruzzi 1, 56124, Pisa, Italy.
| |
Collapse
|
4
|
Farina F, Laezza M, Fasano A, Del Pozzo G. In vitro differentiation of macrophages from peripheral blood cells of celiac patients. Methods Cell Biol 2023; 179:103-112. [PMID: 37625868 DOI: 10.1016/bs.mcb.2023.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/27/2023]
Abstract
Macrophages have both a protective and pathological role in many autoimmune and inflammatory diseases. Macrophages phenotype is regulated by the environment that affects their polarization toward a pro- or anti-inflammatory phenotype. We describe a protocol for in vitro differentiation of macrophages from blood peripheral monocytes, that may be adopted to study different pathologies. Here, we are interested to study the phenotype of macrophages differentiated from patients affected by acute celiac disease (CD) or subjects following a gluten free diet (GFD), after in vitro gliadin challenge. We assess the pro-inflammatory phenotype of these macrophages by cytokines quantization on the cell supernatant. Moreover, our proposed protocol allows the preparation of total RNA to analyze the expression profile of many genes.
Collapse
Affiliation(s)
- Federica Farina
- European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy
| | - Mariavittoria Laezza
- Institute of Genetics and Biophysics "A. Buzzati-Traverso", Italian National Council of Research (CNR), Naples, Italy
| | - Alessio Fasano
- European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy; Division of Pediatric Gastroenterology and Nutrition, Center for Celiac Research and Treatment, Mucosal Immunology and Biology Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics "A. Buzzati-Traverso", Italian National Council of Research (CNR), Naples, Italy.
| |
Collapse
|
5
|
Farina F, Pisapia L, Laezza M, Serena G, Rispo A, Ricciolino S, Gianfrani C, Fasano A, Del Pozzo G. Effect of Gliadin Stimulation on HLA-DQ2.5 Gene Expression in Macrophages from Adult Celiac Disease Patients. Biomedicines 2021; 10:biomedicines10010063. [PMID: 35052743 PMCID: PMC8773327 DOI: 10.3390/biomedicines10010063] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Revised: 12/21/2021] [Accepted: 12/23/2021] [Indexed: 11/16/2022] Open
Abstract
Macrophages play an important role in the pathogenesis of celiac disease (CD) because they are involved in both inflammatory reaction and antigen presentation. We analyzed the expression of CD-associated HLA-DQ2.5 risk alleles on macrophages isolated by two cohorts of adult patients, from the U.S. and Italy, at different stages of disease and with different genotypes. After isolating and differentiating macrophages from PBMC, we assessed the HLA genotype and quantified the HLA-DQ2.5 mRNAs by qPCR, before and after gliadin stimulation. The results confirmed the differences in expression between DQA1*05:01 and DQB1*02:01 predisposing alleles and the non-CD associated alleles, as previously shown on other types of APCs. The gliadin challenge confirmed the differentiation of macrophages toward a proinflammatory phenotype, but above all, it triggered an increase of DQA1*05:01 mRNA, as well as a decrease of the DQB1*02:01 transcript. Furthermore, we observed a decrease in the DRB1 genes expression and a downregulation of the CIITA transactivator. In conclusion, our findings provide new evidences on the non-coordinated regulation of celiac disease DQ2.5 risk genes and support the hypothesis that gliadin could interfere in the three-dimensional arrangement of chromatin at the HLA locus.
Collapse
Affiliation(s)
- Federica Farina
- Institute of Genetics and Biophysics “A. Buzzati-Traverso”, Italian National Council of Research (CNR), 80131 Naples, Italy; (F.F.); (L.P.); (M.L.)
| | - Laura Pisapia
- Institute of Genetics and Biophysics “A. Buzzati-Traverso”, Italian National Council of Research (CNR), 80131 Naples, Italy; (F.F.); (L.P.); (M.L.)
| | - Mariavittoria Laezza
- Institute of Genetics and Biophysics “A. Buzzati-Traverso”, Italian National Council of Research (CNR), 80131 Naples, Italy; (F.F.); (L.P.); (M.L.)
| | - Gloria Serena
- Division of Pediatric Gastroenterology and Nutrition, Center for Celiac Research, Mucosal Immunology and Biology Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA; (G.S.); (A.F.)
| | - Antonio Rispo
- Gastroenterology, Department of Clinical Medicine and Surgery, School of Medicine Federico II of Naples, 80131 Naples, Italy; (A.R.); (S.R.)
| | - Simona Ricciolino
- Gastroenterology, Department of Clinical Medicine and Surgery, School of Medicine Federico II of Naples, 80131 Naples, Italy; (A.R.); (S.R.)
| | - Carmen Gianfrani
- Institute of Biochemistry and Cell Biology, Italian National Council of Research (CNR), 80131 Naples, Italy;
| | - Alessio Fasano
- Division of Pediatric Gastroenterology and Nutrition, Center for Celiac Research, Mucosal Immunology and Biology Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA; (G.S.); (A.F.)
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics “A. Buzzati-Traverso”, Italian National Council of Research (CNR), 80131 Naples, Italy; (F.F.); (L.P.); (M.L.)
- Correspondence:
| |
Collapse
|
6
|
Pisapia L, Terreri S, Barba P, Mastroianni M, Donnini M, Mercadante V, Palmieri A, Verze P, Mirone V, Altieri V, Califano G, Liguori GL, Strazzullo M, Cimmino A, Del Pozzo G. Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis. Biology (Basel) 2020; 9:E66. [PMID: 32244410 PMCID: PMC7235711 DOI: 10.3390/biology9040066] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 03/23/2020] [Accepted: 03/26/2020] [Indexed: 12/13/2022]
Abstract
BACKGROUND Many pseudogenes possess biological activities and play important roles in the pathogenesis of various types of cancer including bladder cancer (BlCa), which still lacks suitable molecular biomarkers. Recently, pseudogenes were found to be significantly enriched in a pan-cancer classification based on the Cancer Genome Atlas gene expression data. Among them, the top-ranking pseudogene was the proliferation-associated 2G4 pseudogene 4 (PA2G4P4). METHODS Genomic and transcript features of PA2G4P4 were determined by GeneBank database analysis followed by 5' RACE experiments. Therefore, we conducted a retrospective molecular study on a cohort of 45 patients of BlCa. PA2G4P4 expression was measured by RT-qPCR, whereas PA2G4P4 transcript distribution was analyzed by in situ hybridization on both normal and cancerous histological sections and compared to the immunolocalization of its parental PA2G4/EBP1 protein. Finally, we tested the effects of PA2G4P4 depletion on proliferation, migration, and death of BlCa cells. RESULTS We showed for the first time PA2G4P4 overexpression in BlCa tissues and in cell lines. PA2G4P4 distribution strictly overlaps PA2G4/EBP1 protein localization. Moreover, we showed that PA2G4P4 knockdown affects both proliferation and migration of BlCa cells, highlighting its potential oncogenic role. CONCLUSIONS PA2G4P4 may play a functional role as an oncogene in BlCa development, suggesting it as a good candidate for future investigation and new clinical applications.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Sara Terreri
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
- B Cell Pathophysiology Unit, IRCCS Bambino Gesù Children’s Hospital, 00146 Rome, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Marianna Mastroianni
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Maria Donnini
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Vincenzo Mercadante
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Alessandro Palmieri
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy; (A.P.); (V.M.); (G.C.)
| | - Paolo Verze
- Department of Medicine and Surgery “Scuola medica Salernitana” University of Salerno, 84084 Salerno, Italy; (P.V.); (V.A.)
| | - Vincenzo Mirone
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy; (A.P.); (V.M.); (G.C.)
| | - Vincenzo Altieri
- Department of Medicine and Surgery “Scuola medica Salernitana” University of Salerno, 84084 Salerno, Italy; (P.V.); (V.A.)
| | - Gianluigi Califano
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy; (A.P.); (V.M.); (G.C.)
| | - Giovanna Lucia Liguori
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Maria Strazzullo
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Amelia Cimmino
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics, CNR, 80131 Naples, Italy; (L.P.); (S.T.); (P.B.); (M.M.); (M.D.); (V.M.); (A.C.)
| |
Collapse
|
7
|
Pisapia L, Hamilton RS, Farina F, D’Agostino V, Barba P, Strazzullo M, Provenzani A, Gianfrani C, Del Pozzo G. Tristetraprolin/ZFP36 Regulates the Turnover of Autoimmune-Associated HLA-DQ mRNAs. Cells 2019; 8:cells8121570. [PMID: 31817224 PMCID: PMC6953012 DOI: 10.3390/cells8121570] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 11/27/2019] [Accepted: 11/28/2019] [Indexed: 12/20/2022] Open
Abstract
HLA class II genes encode highly polymorphic heterodimeric proteins functioning to present antigens to T cells and stimulate a specific immune response. Many HLA genes are strongly associated with autoimmune diseases as they stimulate self-antigen specific CD4+ T cells driving pathogenic responses against host tissues or organs. High expression of HLA class II risk genes is associated with autoimmune diseases, influencing the strength of the CD4+ T-mediated autoimmune response. The expression of HLA class II genes is regulated at both transcriptional and post-transcriptional levels. Protein components of the RNP complex binding the 3'UTR and affecting mRNA processing have previously been identified. Following on from this, the regulation of HLA-DQ2.5 risk genes, the main susceptibility genetic factor for celiac disease (CD), was investigated. The DQ2.5 molecule, encoded by HLA-DQA1*05 and HLA-DQB1*02 alleles, presents the antigenic gluten peptides to CD4+ T lymphocytes, activating the autoimmune response. The zinc-finger protein Tristetraprolin (TTP) or ZFP36 was identified to be a component of the RNP complex and has been described as a factor modulating mRNA stability. The 3'UTR of CD-associated HLA-DQA1*05 and HLA-DQB1*02 mRNAs do not contain canonical TTP binding consensus sequences, therefore an in silico approach focusing on mRNA secondary structure accessibility and stability was undertaken. Key structural differences specific to the CD-associated mRNAs were uncovered, allowing them to strongly interact with TTP through their 3'UTR, conferring a rapid turnover, in contrast to lower affinity binding to HLA non-CD associated mRNA.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso” CNR, Via Pietro Castellino, 111, 80131 Naples, Italy; (L.P.); (F.F.); (P.B.); (M.S.)
| | - Russell S. Hamilton
- Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Site, Cambridge CB2 3DY, UK;
| | - Federica Farina
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso” CNR, Via Pietro Castellino, 111, 80131 Naples, Italy; (L.P.); (F.F.); (P.B.); (M.S.)
| | - Vito D’Agostino
- Centre for Cellular, Computational and Integrative Biology-CIBIO, University of Trento, via Sommarive 9, 38123 Trento, Italy; (V.D.); (A.P.)
| | - Pasquale Barba
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso” CNR, Via Pietro Castellino, 111, 80131 Naples, Italy; (L.P.); (F.F.); (P.B.); (M.S.)
| | - Maria Strazzullo
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso” CNR, Via Pietro Castellino, 111, 80131 Naples, Italy; (L.P.); (F.F.); (P.B.); (M.S.)
| | - Alessandro Provenzani
- Centre for Cellular, Computational and Integrative Biology-CIBIO, University of Trento, via Sommarive 9, 38123 Trento, Italy; (V.D.); (A.P.)
| | - Carmen Gianfrani
- Institute of Biochemistry and Cell Biology-CNR, Via Pietro Castellino, 111, 80131 Naples, Italy;
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics “Adriano Buzzati Traverso” CNR, Via Pietro Castellino, 111, 80131 Naples, Italy; (L.P.); (F.F.); (P.B.); (M.S.)
- Correspondence:
| |
Collapse
|
8
|
Pisapia L, Cerillo I, Farina F, Zimbardo A, Barba P, Orefice G, Gianfrani C, Strazzullo M, Del Pozzo G. The HLA-DRB1 risk alleles for multiple sclerosis are differentially expressed in blood cells of patients from Southern Italy. Int J Immunogenet 2019; 46:479-484. [PMID: 31313885 DOI: 10.1111/iji.12450] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 06/05/2019] [Accepted: 06/18/2019] [Indexed: 11/28/2022]
Abstract
HLA gene expression has an important role in the autoimmune disease predisposition. We investigated the mRNA expression profile of the risk alleles HLA-DRB1*15 and HLA-DRB1*13 in a cohort of subjects both multiple sclerosis (MS) patients and healthy controls. Moreover, we explored the expression of the allele HLA-DRB1*11 that is very frequent in our cohort from southern Italy. We found that the expression of MS-associated alleles in heterozygous MS patients was always higher than the nonassociated alleles. The differential risk allele expression occurred also in nonaffected subjects, though with a lower increment compared to MS patients.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics-CNR, Naples, Italy
| | - Ilaria Cerillo
- Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Naples, Italy
| | | | | | | | - Giuseppe Orefice
- Department of Neuroscience, Reproductive Sciences and Dentistry- University Federico II, Naples, Italy
| | | | | | | |
Collapse
|
9
|
Gianfrani C, Pisapia L, Picascia S, Strazzullo M, Del Pozzo G. Expression level of risk genes of MHC class II is a susceptibility factor for autoimmunity: New insights. J Autoimmun 2018; 89:1-10. [PMID: 29331322 DOI: 10.1016/j.jaut.2017.12.016] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2017] [Revised: 12/28/2017] [Accepted: 12/29/2017] [Indexed: 02/08/2023]
Abstract
To date, the study of the impact of major hystocompatibility complex on autoimmunity has been prevalently focused on structural diversity of MHC molecules in binding and presentation of (auto)antigens to cognate T cells. Recently, a number of experimental evidences suggested new points of view to investigate the complex relationships between MHC gene expression and the individual predisposition to autoimmune diseases. Irrespective of the nature of the antigen, a threshold of MHC-peptide complexes needs to be reached, as well as a threshold of T cell receptors engaged is required, for the activation and proliferation of autoantigen-reactive T cells. Moreover, it is well known that increased expression of MHC class II molecules may alter the T cell receptor repertoire during thymic development, and affect the survival and expansion of mature T cells. Many evidences confirmed that the level of both transcriptional and post-transcriptional regulation are involved in the modulation of the expression of MHC class II genes and that both contribute to the predisposition to autoimmune diseases. Here, we aim to focus some of these regulative aspects to better clarify the role of MHC class II genes in predisposition and development of autoimmunity.
Collapse
Affiliation(s)
- Carmen Gianfrani
- Institute of Protein Biochemistry-CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Laura Pisapia
- Institute of Genetics and Biophysics-CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Stefania Picascia
- Institute of Protein Biochemistry-CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Maria Strazzullo
- Institute of Genetics and Biophysics-CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics-CNR, Via Pietro Castellino 111, 80131, Naples, Italy.
| |
Collapse
|
10
|
Vitale S, Strisciuglio C, Pisapia L, Miele E, Barba P, Vitale A, Cenni S, Bassi V, Maglio M, Del Pozzo G, Troncone R, Staiano A, Gianfrani C. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease. PLoS One 2017; 12:e0182313. [PMID: 28797042 PMCID: PMC5552230 DOI: 10.1371/journal.pone.0182313] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2016] [Accepted: 07/17/2017] [Indexed: 02/07/2023] Open
Abstract
In the recent years, the incidence of inflammatory bowel disease (IBD) has dramatically increased in young subjects, however, the pathogenesis of paediatric IBD is poorly investigated. In this study we aimed to evaluate the cytokine pattern and the phenotype of cytokine producing cells in the intestinal mucosa of paediatric patients affected by Crohn’s disease (CD) or ulcerative colitis (UC) and of non-IBD healthy controls (HC). Cytokine (IL-15, TNF-α, INF-γ) production was analyzed at basal condition and after mitogen stimulation either intracellularly by flow cytometry or in intestinal cell culture supernatants by enzyme-linked immunosorbent assay (ELISA). A higher frequency of enterocytes (EpCam+ cells) was observed in UC patients compared to CD or HC. An expansion of enterocytes producing IL-15 and TNF-α were found in IBD patients compared to HC. A marked expression of IL-15 in the intestinal epithelium of IBD patients was further confirmed by immunohistochemistry. Myeloid dendritic (CD11c+) cells producing TNF-α and INF-γ were increased in IBD biopsies. Unexpectedly, only after a strong mitogen stimulus, as phytohaemagglutinin, the frequency of CD3+ cells producing IFN-γ was increased in IBD compared to control intestinal mucosa. Interestingly, functional studies performed on organ cultures of intestinal biopsies with neutralizing anti-IL-15 monoclonal antibody showed a marked reduction of mononuclear cell activation, proliferation of crypt enterocytes, as well as a reduction of TNF-α release in organ culture supernatants. In conclusion, we found that in the gut mucosa of IBD children both enterocytes and dendritic cells produce proinflammatory cytokines. The over-expression of IL-15 by enterocytes in IBD intestine and the reduced IBD inflammation by IL-15 blockage suggests that this cytokine could be a therapeutic target in IBD.
Collapse
Affiliation(s)
- Serena Vitale
- Institute of Protein Biochemistry, CNR, Naples, Italy
| | - Caterina Strisciuglio
- Department of Woman, Child and General and Specialized Surgery, Second University of Naples, Naples, Italy
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Laura Pisapia
- Institute of Genetics and Biophysics Adriano Buzzati Traverso, CNR, Naples, Italy
| | - Erasmo Miele
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics Adriano Buzzati Traverso, CNR, Naples, Italy
| | - Alessandra Vitale
- Department of Woman, Child and General and Specialized Surgery, Second University of Naples, Naples, Italy
| | - Sabrina Cenni
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Virginia Bassi
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Mariantonia Maglio
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics Adriano Buzzati Traverso, CNR, Naples, Italy
| | - Riccardo Troncone
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Annamaria Staiano
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
| | - Carmen Gianfrani
- Institute of Protein Biochemistry, CNR, Naples, Italy
- Department of Translational Medical Science (Section of Paediatrics), and European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy
- * E-mail:
| |
Collapse
|
11
|
Pisapia L, Camarca A, Picascia S, Bassi V, Barba P, Del Pozzo G, Gianfrani C. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response. J Autoimmun 2016; 70:63-72. [PMID: 27083396 DOI: 10.1016/j.jaut.2016.03.016] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Revised: 03/30/2016] [Accepted: 03/30/2016] [Indexed: 12/20/2022]
Abstract
HLA genes represent the main risk factor in autoimmune disorders. In celiac disease (CD), the great majority of patients carry the HLA DQA1*05 and DQB1*02 alleles, both of which encode the DQ2.5 molecule. The formation of complexes between DQ2.5 and gluten peptides on antigen-presenting cells (APCs) is necessary to activate pathogenic CD4(+) T lymphocytes. It is widely accepted that the DQ2.5 genes establish the different intensities of anti-gluten immunity, depending whether they are in a homozygous or a heterozygous configuration. Here, we demonstrated that HLA DQA1*05 and DQB1*02 gene expression is much higher than expression of non-CD-associated genes. This influences the protein levels and causes a comparable cell surface exposure of DQ2.5 heterodimers between DQ2.5 homozygous and heterozygous celiac patients. As a consequence, the magnitude of the anti-gluten CD4(+) T cell response is strictly dependent on the antigen dose and not on the DQ2.5 gene configuration of APCs. Furthermore, our findings support the concept that the expression of DQ2.5 genes is an important risk factor in celiac disease. The preferential expression of DQ2.5 alleles provides a new functional explanation of why these genes are so frequently associated with celiac disease and with other autoimmune disorders.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics "Adriano Buzzati Traverso" - CNR, Via Pietro Castellino, 111, 80131, Naples, Italy
| | | | - Stefania Picascia
- Institute of Protein Biochemistry-CNR, Via Pietro Castellino, 111, 80131, Naples, Italy
| | - Virginia Bassi
- Institute of Food Sciences-CNR, Via Roma 52, 83100, Avellino, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics "Adriano Buzzati Traverso" - CNR, Via Pietro Castellino, 111, 80131, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics "Adriano Buzzati Traverso" - CNR, Via Pietro Castellino, 111, 80131, Naples, Italy.
| | - Carmen Gianfrani
- Institute of Protein Biochemistry-CNR, Via Pietro Castellino, 111, 80131, Naples, Italy.
| |
Collapse
|
12
|
Pisapia L, Barba P, Cortese A, Cicatiello V, Morelli F, Del Pozzo G. EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells. Int J Oncol 2015; 47:481-9. [PMID: 26081906 PMCID: PMC4501648 DOI: 10.3892/ijo.2015.3051] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2015] [Accepted: 05/04/2015] [Indexed: 12/11/2022] Open
Abstract
Many solid tumours including melanoma, glioblastoma, and breast carcinomas express MHC class II molecules (MHC II). The surface expression of these molecules confers to non-hematopoietic tumour cells the role of non-professional antigen presenting cells and the ability to potentially stimulate tumour-specific CD4+ T cell response. We studied EBP1, an ErbB3 binding protein, and the effects of p48 and p42 isoforms on the MHC II expression in U87 glioblastoma, M14 melanoma and MCF7 mammary carcinoma cell lines. We found that overexpression of p48 increases MHC II transcription in U87 and M14, through upregulation of CIITA transactivator and STAT1 phosphorylation. In addition, p48 protein influences MHC II expression by increasing mRNA stability. In melanoma and glioblastoma cell lines, p48 isoform functions as oncogene promoting tumour growth, while p42 isoform, that does not affect MHC II expression, acts as a tumour suppressor by blocking cell growth and inducing apoptosis. In contrast, p48 seems to act as tumour suppressor in breast carcinoma inhibiting proliferation, favouring apoptosis, and inducing a slight increase of MHC II expression similar to p42. Our data highlight the tissue specificity function of EBP1 isoforms and demonstrate that only the oncogene p48 activates MHC II expression in human solid tumours, via STAT1 phosphorylation, in order to affect tumour progression by triggering specific immune response.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| | - Angela Cortese
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| | - Valeria Cicatiello
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| | - Franco Morelli
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics 'Adriano Buzzati Traverso'-CNR, 80131 Naples, Italy
| |
Collapse
|
13
|
Pisapia L, Cicatiello V, Barba P, Malanga D, Maffei A, Hamilton RS, Del Pozzo G. Co-regulated expression of alpha and beta mRNAs encoding HLA-DR surface heterodimers is mediated by the MHCII RNA operon. Nucleic Acids Res 2013; 41:3772-86. [PMID: 23393186 PMCID: PMC3616700 DOI: 10.1093/nar/gkt059] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Major histocompatibility complex class II (MHCII) molecules are heterodimeric surface proteins involved in the presentation of exogenous antigens during the adaptive immune response. We demonstrate the existence of a fine level of regulation, coupling the transcription and processing of mRNAs encoding α and β chains of MHCII molecules, mediated through binding of their Untraslated Regions (UTRs) to the same ribonucleoproteic complex (RNP). We propose a dynamic model, in the context of the 'MHCII RNA operon' in which the increasing levels of DRA and DRB mRNAs are docked by the RNP acting as a bridge between 5'- and 3'-UTR of the same messenger, building a loop structure and, at the same time, joining the two chains, thanks to shared common predicted secondary structure motifs. According to cell needs, as during immune surveillance, this RNP machinery guarantees a balanced synthesis of DRA and DRB mRNAs and a consequent balanced surface expression of the heterodimer.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics Adriano Buzzati Traverso-CNR, Naples, 80131, Italy
| | | | | | | | | | | | | |
Collapse
|
14
|
Pisapia L, Pozzo GD, Barba P, Citro A, Harris PE, Maffei A. Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter. Results Immunol 2012; 2:174-83. [PMID: 24371581 DOI: 10.1016/j.rinim.2012.09.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 07/31/2012] [Revised: 09/16/2012] [Accepted: 09/19/2012] [Indexed: 01/01/2023]
Abstract
We previously demonstrated that, in ex vivo cultures, IFNα downregulates the expression of MHC class II (MHCII) genes in human non-professional APCs associated with pancreatic islets. IFNα has an opposing effect on MHCII expression in professional APCs. In this study, we found that the mechanism responsible for the IFNα-mediated MHCII's downregulation in human MHCII-positive non-professional antigen presenting human non-hematopoietic cell lines is the result of the negative feedback system that regulates cytokine signal transduction, which eventually inhibits promoters III and IV of CIITA gene. Because the CIITA-PIV isoform is mostly responsible for the constitutive expression of MHCII genes in non-professional APCs, we pursued and achieved the specific knockdown of CIITA-PIV mRNA in our in vitro system, obtaining a partial silencing of MHCII molecules similar to that obtained by IFNα. We believe that our results offer a new understanding of the potential significance of CIITA-PIV as a therapeutic target for interventional strategies that can manage autoimmune disease and allograft rejection with little interference on the function of professional APCs of the immune system.
Collapse
Affiliation(s)
- Laura Pisapia
- Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy
| | - Alessandra Citro
- Department of Medicine of Columbia University Medical Center, New York, NY, USA
| | - Paul E Harris
- Department of Medicine of Columbia University Medical Center, New York, NY, USA
| | - Antonella Maffei
- Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy ; Department of Medicine of Columbia University Medical Center, New York, NY, USA
| |
Collapse
|
15
|
Sartorius R, Bettua C, D'Apice L, Caivano A, Trovato M, Russo D, Zanoni I, Granucci F, Mascolo D, Barba P, Del Pozzo G, De Berardinis P. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants. Eur J Immunol 2011; 41:2573-84. [PMID: 21688262 DOI: 10.1002/eji.201141526] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2011] [Revised: 06/09/2011] [Accepted: 06/15/2011] [Indexed: 12/30/2022]
Abstract
The efficacy of a new vaccine-delivery vector, based on the filamentous bacteriophage fd displaying a single-chain antibody fragment known to bind the mouse DC surface molecule DEC-205, is reported. We demonstrate both in vitro and in vivo an enhanced receptor-mediated uptake of phage particles expressing the anti-DEC-205 fragment by DCs. We also report that DCs targeted by fd virions in the absence of other stimuli produce IFN-α and IL-6, and acquire a mature phenotype. Moreover, DC-targeting with fd particles double-displaying the anti-DEC-205 fragment on the pIII protein and the OVA(257-264) antigenic determinant on the pVIII protein induced potent inhibition of the growth of the B16-OVA tumor in vivo. This protection was much stronger than other immunization strategies and similar to that induced by adoptively transferred DCs. Since targeting DEC-205 in the absence of DC activation/maturation agents has previously been described to result in tolerance, the ability of fd bacteriophages to induce a strong tumor-specific immune response by targeting DCs through DEC-205 is unexpected, and further validates the potential employment of this safe, versatile and inexpensive delivery system for vaccine formulation.
Collapse
|
16
|
Corso C, Pisapia L, Citro A, Cicatiello V, Barba P, Cigliano L, Abrescia P, Maffei A, Manco G, Del Pozzo G. EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon. Nucleic Acids Res 2011; 39:7263-75. [PMID: 21624892 PMCID: PMC3167597 DOI: 10.1093/nar/gkr278] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Major histocompatibility complex class II mRNAs encode heterodimeric proteins involved in the presentation of exogenous antigens during an immune response. Their 3'UTRs bind a protein complex in which we identified two factors: EBP1, an ErbB3 receptor-binding protein and DRBP76, a double-stranded RNA binding nuclear protein, also known as nuclear factor 90 (NF90). Both are well-characterized regulatory factors of several mRNA molecules processing. Using either EBP1 or DRBP76/NF90-specific knockdown experiments, we established that the two proteins play a role in regulating the expression of HLA-DRA, HLA-DRB1 and HLA-DQA1 mRNAs levels. Our study represents the first indication of the existence of a functional unit that includes different transcripts involved in the adaptive immune response. We propose that the concept of 'RNA operon' may be suitable for our system in which MHCII mRNAs are modulated via interaction of their 3'UTR with same proteins.
Collapse
Affiliation(s)
- Carmela Corso
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Laura Pisapia
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Alessandra Citro
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Valeria Cicatiello
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
- *To whom correspondence should be addressed. Valeria Cicatiello. Tel: +390816132455; Fax: +390816132718;
| | - Pasquale Barba
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Luisa Cigliano
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Paolo Abrescia
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Antonella Maffei
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| | - Giuseppe Manco
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
- *To whom correspondence should be addressed. Valeria Cicatiello. Tel: +390816132455; Fax: +390816132718;
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics ‘A. Buzzati Traverso’, CNR, Via Pietro Castellino 111, 80131, Naples, Department of Biological Science, University of Naples Federico II, Via Mezzocannone 8, 80134, Naples and Institute of Protein Biochemistry, CNR, Via Pietro Castellino 111, 80131, Naples, Italy
| |
Collapse
|
17
|
Bontempo P, Mita L, Doto A, Miceli M, Nebbioso A, Lepore I, Franci G, Menafra R, Carafa V, Conte M, De Bellis F, Manzo F, Di Cerbo V, Benedetti R, D'Amato L, Marino M, Bolli A, Del Pozzo G, Diano N, Portaccio M, Mita GD, Vietri MT, Cioffi M, Nola E, Dell'aversana C, Sica V, Molinari AM, Altucci L. Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells. J Transl Med 2009; 7:48. [PMID: 19538739 PMCID: PMC2717713 DOI: 10.1186/1479-5876-7-48] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2009] [Accepted: 06/18/2009] [Indexed: 11/23/2022] Open
Abstract
Background: BPA (bisphenol A or 2,2-bis(4-hydroxy-phenol)propane) is present in the manufacture of polycarbonate plastic and epoxy resins, which can be used in impact-resistant safety equipment and baby bottles, as protective coatings inside metal food containers, and as composites and sealants in dentistry. Recently, attention has focused on the estrogen-like and carcinogenic adverse effects of BPA. Thus, it is necessary to investigate the cytotoxicity and apoptosis-inducing activity of this compound. Methods: Cell cycle, apoptosis and differentiation analyses; western blots. Results: BPA is able to induce cell cycle arrest and apoptosis in three different acute myeloid leukemias. Although some granulocytic differentiation concomitantly occurred in NB4 cells upon BPA treatment, the major action was the induction of apoptosis. BPA mediated apoptosis was caspase dependent and occurred by activation of extrinsic and intrinsic cell death pathways modulating both FAS and TRAIL and by inducing BAD phosphorylation in NB4 cells. Finally, also non genomic actions such as the early decrease of both ERK and AKT phosphorylation were induced by BPA thus indicating that a complex intersection of regulations occur for the apoptotic action of BPA. Conclusion: BPA is able to induce apoptosis in leukemia cells via caspase activation and involvement of both intrinsic and extrinsic pathways of apoptosis.
Collapse
Affiliation(s)
- Paola Bontempo
- Dipartimento di Patologia generale, Seconda Università di Napoli, Via L, De Crecchio 7, Napoli, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Ulivieri C, Citro A, Ivaldi F, Mascolo D, Ghittoni R, Fanigliulo D, Manca F, Baldari CT, Li Pira G, Del Pozzo G. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Immunol Lett 2008; 119:62-70. [PMID: 18538862 DOI: 10.1016/j.imlet.2008.04.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2008] [Revised: 04/10/2008] [Accepted: 04/22/2008] [Indexed: 11/26/2022]
Abstract
Several efforts have been invested in the identification of CTL and Th epitopes, as well as in the characterization of their immunodominance and MHC restriction, for the generation of a peptide-based HCMV vaccine. Small synthetic peptides are, however, poor antigens and carrier proteins are important for improving the efficacy of synthetic peptide vaccines. Recombinant bacteriophages appear as promising tools in the design of subunit vaccines. To investigate the antigenicity of peptides carried by recombinant bacteriophages we displayed different HCMV MHCII restricted peptides on the capsid of filamentous bacteriophage (fd) and found that hybrid bacteriophages are processed by human APC and activate HCMV-specific CD4 T-cells. Furthermore we constructed a reporter T-cell hybridoma expressing a chimeric TCR comprising murine alphabeta constant regions and human variable regions specific for the HLA-A2 restricted immunodominant NLV peptide of HCMV. Using the filamentous bacteriophage as an epitope carrier, we detected a more robust and long lasting response of the reporter T-cell hybridoma compared to peptide stimulation. Our results show a general enhancement of T-cell responses when antigenic peptides are carried by phages.
Collapse
Affiliation(s)
- Cristina Ulivieri
- Department of Evolutionary Biology, University of Siena, Via A. Moro 2, 53100 Siena, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Mascolo D, Barba P, De Berardinis P, Di Rosa F, Del Pozzo G. Phage display of a CTL epitope elicits a long-term in vivo cytotoxic response. FEMS Immunol Med Microbiol 2007; 50:59-66. [PMID: 17391361 PMCID: PMC7110391 DOI: 10.1111/j.1574-695x.2007.00229.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/20/2006] [Revised: 12/18/2006] [Accepted: 01/23/2007] [Indexed: 11/30/2022]
Abstract
The Ovalbumin(257-264) CTL epitope on the major coat protein of the filamentous bacteriophage in different antigen formulations was displayed and the immune response in C57BL6/J mice studied. The display of single cytotoxic epitope on the surface of the virion is sufficient to induce priming and sustain long-term major histocompatibility complex class I restricted cytotoxic T lymphocytes response in vivo. The filamentous bacteriophage is a versatile carrier able to display simultaneously either single or multiple epitopes and can elicit a cellular response carrying very little peptide (<1.5 microg).
Collapse
Affiliation(s)
- Dina Mascolo
- Institute of Genetics and Biophysics ‘Adriano Buzzati Traverso’, CNR, Naples, Italy
| | - Pasquale Barba
- Institute of Genetics and Biophysics ‘Adriano Buzzati Traverso’, CNR, Naples, Italy
| | | | - Francesca Di Rosa
- Institute of Genetics and Biophysics ‘Adriano Buzzati Traverso’, CNR, Naples, Italy
| | - Giovanna Del Pozzo
- Institute of Genetics and Biophysics ‘Adriano Buzzati Traverso’, CNR, Naples, Italy
| |
Collapse
|
20
|
Malanga D, Barba P, Harris PE, Maffei A, Del Pozzo G. The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface pool. Cell Immunol 2007; 246:75-80. [PMID: 17662701 DOI: 10.1016/j.cellimm.2007.06.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2007] [Revised: 06/11/2007] [Accepted: 06/12/2007] [Indexed: 11/24/2022]
Abstract
The transition of human dendritic cells (DCs) from the immature to the mature phenotype is characterized by an increased density of MHC class II (MHCII) molecules on the plasma membrane, a key requirement of their competence as professional antigen presenting cells (APCs). MHCII molecules on the cell surface derive from newly synthesized as well as from preexisting proteins. So far, all the studies done on DCs during maturation, to establish the relative contribution of newly synthesized MHCII molecules to the cell surface pool did not produced a clear, unified scenario. We report that, in human DCs stimulated ex vivo with LPS, the changes in the RNA accumulation specific for at least two MHCII genes (HLA-DRA and HLA-DQA1) due to transcriptional upregulation, is associated with the active translation at high rate of these transcripts. Our finding reveals that, across the 24h of the maturation process in human DCs, newly synthesized MHCII proteins are supplied to the APCs cell surface pool.
Collapse
Affiliation(s)
- Donatella Malanga
- Institute of Genetics and Biophysics "A. Buzzati-Traverso", CNR, Naples, Italy
| | | | | | | | | |
Collapse
|
21
|
D'Apice L, Sartorius R, Caivano A, Mascolo D, Del Pozzo G, Di Mase DS, Ricca E, Li Pira G, Manca F, Malanga D, De Palma R, De Berardinis P. Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems. Vaccine 2006; 25:1993-2000. [PMID: 17239998 DOI: 10.1016/j.vaccine.2006.11.047] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2006] [Revised: 11/03/2006] [Accepted: 11/23/2006] [Indexed: 01/20/2023]
Abstract
A T helper epitope was expressed in three innovative delivery vehicles recently developed in our laboratories and based respectively, on the filamentous bacteriophage fd, the E2 protein from the PDH complex of Bacillus stearothermophilus and the protein CotC of Bacillus subtilis spores. Studies of antigenicity and immunogenicity were performed by using a specific T cell hybridoma and by priming mononuclear cells isolated from the venous blood of human donors. The results indicate that the E2 system is the best suited for inducing a specific immune response towards a CD4 T cell epitope. Importantly, TCR clonal analysis demonstrated the persistence over years of a previously described antigen specific clonotype and its presence correlates with the immunogenic strength of the antigen delivery system.
Collapse
Affiliation(s)
- Luciana D'Apice
- Institute of Protein Biochemistry, C.N.R.,Via P. Castellino 111, 80131 Naples, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Harris PE, Malanga D, Liu Z, Hardy MA, Souza F, Del Pozzo G, Winchester RJ, Maffei A. Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue. Biochim Biophys Acta Mol Basis Dis 2006; 1762:627-35. [PMID: 16782520 DOI: 10.1016/j.bbadis.2006.05.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2006] [Revised: 05/05/2006] [Accepted: 05/09/2006] [Indexed: 10/24/2022]
Abstract
Type 1 diabetes (T1D) is caused by autoimmune destruction of the insulin-producing beta-cells of the islets of Langerhans. One still open question is where naive islet-reactive T cells encounter antigens and become stimulated. In this report we have re-examined the expression of MHC class II (MHCII) genes in human islets to further explore the possibility that non-professional antigen presenting cells (APCs) within islets contribute to autoimmunity. Since development of T1D has been linked to viral infections, we also studied ex-vivo MHCII expression in response to interferon-alpha (IFNalpha) in islet tissue and in different APCs. The findings are: first, MHCII genes expression in human islets is linked with the expression of the class II transactivator isoform transcribed from the promoter IV, similar to that described in non-professional APCs. Second, there is IFNalpha-mediated lineage-specific regulation of MHCII genes expression, seen as a decrease in the accumulation of MHCII transcripts in pancreatic islets opposite to an increase in dendritic cells and B-lymphoblastoid cell lines. Third, there is allele-specific regulation of the HLA-DQA1 gene by IFNalpha in islet tissue. These findings may begin to explain the molecular events that create favorable conditions for organ-specific autoimmunity and explain the incomplete penetrance of T1D susceptibility alleles.
Collapse
Affiliation(s)
- Paul E Harris
- Institute of Genetics and Biophysics Adriano Buzzati-Traverso, Consiglio Nazionale delle Ricerche, Naples, Italy
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Maffei A, Liu Z, Witkowski P, Moschella F, Del Pozzo G, Liu E, Herold K, Winchester RJ, Hardy MA, Harris PE. Identification of tissue-restricted transcripts in human islets. Endocrinology 2004; 145:4513-21. [PMID: 15231694 DOI: 10.1210/en.2004-0691] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The purpose of our study was to identify transcripts specific for tissue-restricted, membrane-associated proteins in human islets that, in turn, might serve as markers of healthy or diseased islet cell masses. Using oligonucleotide chips, we obtained gene expression profiles of human islets for comparison with the profiles of exocrine pancreas, liver, and kidney tissue. As periislet presence of type 1 interferon is associated with the development of type 1 diabetes, the expression profile of human islets treated ex vivo with interferon-alpha2beta (IFNalpha2beta) was also determined. A set of genes encoding transmembrane- or membrane-associated proteins with novel islet-restricted expression was resolved by determining the intersection of the islet set with the complement of datasets obtained from other tissues. Under the influence of IFNalpha2beta, the expression levels of transcripts for several of the identified gene products were up- or down-regulated. One of the islet-restricted gene products identified in this study, vesicular monoamine transporter type 2, was shown to bind [3H]dihydrotetrabenazine, a ligand with derivatives suitable for positron emission tomography imaging. We report here the first comparison of gene expression profiles of human islets with other tissues and the identification of a target molecule with possible use in determining islet cell masses.
Collapse
Affiliation(s)
- Antonella Maffei
- Institute of Genetics and Biophysics Adriano Buzzati-Traverso, National Research Center, Naples, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
De Berardinis P, Sartorius R, Caivano A, Mascolo D, Domingo GJ, Del Pozzo G, Gaubin M, Perham RN, Piatier-Tonneau D, Guardiola J. Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. Curr HIV Res 2004; 1:441-6. [PMID: 15049429 DOI: 10.2174/1570162033485168] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Two non-pathogenic scaffolds (represented by the filamentous bacteriophage fd and the dihydrolipoyl acetyltransferase E2 protein of the Bacillus stearothermophilus pyruvate dehydrogenase (PDH) complex) able to deliver human immunodeficiency virus (HIV)-1 antigenic determinants, were designed in our laboratories and investigated in controlled assay conditions. Based on a modification of the phage display technology, we developed an innovative concept for a safe and inexpensive vaccine in which conserved antigenic determinants of HIV-1 reverse transcriptase (RTase) were inserted into the N-terminal region of the major pVIII coat protein of bacteriophagefd virions. Analogously, we developed another antigen delivery system based on the E2 component from the PDH complex and capable of displaying large intact proteins on the surface of an icosahedral lattice. Our data show that both of these systems can deliver B and T epitopes to their respective presentation compartments in target cells and trigger a humoral response as well as a potent helper and cytolytic response in vitro and in vivo.
Collapse
|
25
|
Del Pozzo G, Mascolo D, Prisco A, Barba P, Anzisi A, Guardiola J. Lack of patent liver autoimmunity after breakage of tolerance in a mouse model. Int Immunol 2003; 15:1173-81. [PMID: 13679387 PMCID: PMC7108624 DOI: 10.1093/intimm/dxg119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We report in this work that a cellular and humoral autoreactive response can be induced against liver-specific self-determinants by repeated immunization with a chimeric tissue-specific self-antigen carrying a heterologous T(h) epitope. Epitope spreading rendering the autoimmune reaction independent of the presence of the cognate heterologous help is also demonstrated. Although neutrophil infiltrates can be demonstrated in the livers of treated mice, no clinical sign of organ damage is observed. These findings suggest that breakage of tolerance by this means leads the process only up to the next checkpoint in the progression of autoimmune disease and that further events are required to precipitate functional organ impairment.
Collapse
Affiliation(s)
- Giovanna Del Pozzo
- Institute of Genetics and Biophysics A. Buzzati Traverso, via G. Marconi 10, 80125, Naples, Italy.
| | | | | | | | | | | |
Collapse
|
26
|
Pero R, Lembo F, Chieffi P, Del Pozzo G, Fedele M, Fusco A, Bruni CB, Chiariotti L. Translational regulation of a novel testis-specific RNF4 transcript. Mol Reprod Dev 2003; 66:1-7. [PMID: 12874792 DOI: 10.1002/mrd.10322] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The RING-finger protein SNURF/RNF4, a modulator of both steroid receptor dependent and basal transcription, is expressed at very high levels in testis and at much lower levels in several other tissues. In somatic tissues, the RNF4 gene is expressed as a 3-kb transcript while an additional shorter sized transcript (1.6 kb) was found in mouse testis. In murine germ cells, RNF4 protein expression is strongly modulated during progression of spermatogonia to spermatids, with a peak in spermatocytes. The expression of 3-kb transcript correlated with protein levels in the different germ cell populations. Conversely, the 1.6-kb transcript was abundantly and specifically expressed in spermatids, in which RNF4 protein was detected at very low levels. We have then examined possible mechanisms underlying this discrepancy. Primer extension and RNase protection analyses demonstrated that the 1.6- and 3.0-kb transcripts originate from the same promoter, encode for the same protein and differ in the 3' UTR. In vitro assays showed that protein degradation is not involved in the regulation of RNF4 protein level. Finally, polysome analysis revealed that only a slight fraction of the testis-specific transcript is engaged in translation, thus providing a feasible mechanism for the quantitative differences of RNF4 mRNA and protein levels. Present results demonstrate that RNF4 short transcript is poorly translated suggesting that this mechanism could be essential for normal spermatogenesis.
Collapse
Affiliation(s)
- Raffaela Pero
- Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, IEOS del C.N.R., Università di Napoli Federico II, Naples, Italy
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Moschella F, Ombra MN, Del Pozzo G, Guardiola J. Administration of different antigenic forms of altered peptide ligands derived from HIV-1 RTase influences their effects on T helper cell activation. Hum Immunol 2003; 64:1-8. [PMID: 12507809 DOI: 10.1016/s0198-8859(02)00783-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Genetic hypervariability of viruses such as HIV-1 facilitates appearance of escape mutants for immune response. HIV-1 isolates display variant epitopes, which may fail to stimulate T-lymphocyte responses or act as natural T-cell receptor antagonists, contributing to viral persistence. We evaluated the effect on epitope specific T-cell reactions of different amino acid substitutions in a residue of the 248-262 sequence of HIV-1 reverse transcriptase (peptide 23), showing variability in different viral isolates. Responses against such a determinant have been detected in long-term nonprogressive patients. The modified antigenic determinant was administered either as synthetic peptide or as recombinant protein. Our results show that certain amino acid substitutions abolished peptide binding to major histocompatibility complex (MHC); other modifications, although not affecting the formation of the MHC/peptide complex, either abrogated T-cell proliferation or exhibited an antagonistic effect. The results suggest that residue 11 of peptide 23 exhibits a double function; its alteration affects both the peptide affinity for the MHC and the MHC/peptide complex affinity for the T-cell receptor. Furthermore, we demonstrated that synthetic ligands and recombinant proteins may produce distinct functional effects, providing evidence that synthetic peptides, compared with corresponding epitopes generated by intracellular processing of recombinant proteins, may bind to the MHC groove in a different conformation.
Collapse
Affiliation(s)
- Federica Moschella
- Division of Medical Oncology, Department of Medicine of the College of Physicians and Surgeons of Columbia University, New York, New York, USA
| | | | | | | |
Collapse
|
28
|
Gaubin M, Fanutti C, Mishal Z, Durrbach A, De Berardinis P, Sartorius R, Del Pozzo G, Guardiola J, Perham RN, Piatier-Tonneau D. Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol 2003; 22:11-8. [PMID: 12590733 DOI: 10.1089/104454903321112451] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
Virions of filamentous bacteriophage fd are capable of displaying multiple copies of peptide epitopes and generating powerful immune responses to them. To investigate the antigen processing mechanisms in human B cell lines used as antigen presenting cells, the major coat protein (pVIII) in intact virions was fluorescently labeled, and its localization in various intracellular compartments was followed using confocal microscopy. We show that the virions were taken up and processed to yield peptides that reach both the major histocompatibility complex (MHC) class II compartment and the endoplasmic reticulum. Moreover, when exposed to bacteriophages displaying a cytotoxic T lymphocyte (CTL) epitope from the reverse transcriptase of human immunodeficiency virus type-1 (HIV-1), B cells were lysed by specific cytotoxic lymphocytes. This confirms that filamentous bacteriophage virions are capable of being taken up and processed efficiently by MHC class I and class II pathways, even in nonprofessional antigen presenting cells. These remarkable features explain, at least in part, the unexpected ability of virions displaying foreign T-cell epitopes to prime strong T-helper-dependent CTL responses. These findings have important implications for the development of peptide-based vaccines, using filamentous bacteriophage virions as scaffolds.
Collapse
Affiliation(s)
- Muriel Gaubin
- Génomique Fonctionnelle et Biologie Systémique en Santé, Centre National de la Recherche Scientifique, Villejuif, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Carriero MV, Franco P, Gargiulo L, Vocca I, Cito L, Fontana L, Iaccarino C, Del Pozzo G, Guardiola J, Stoppelli MP. Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions. Biol Chem 2002; 383:107-13. [PMID: 11928806 DOI: 10.1515/bc.2002.011] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We have previously reported that phosphorylation of human urokinase on Ser138/303 abolishes its catalytic-independent motogen and proadhesive abilities, whereas receptor binding is not affected. Here we show that substitution of the two relevant serines with glutamic acid residues impairs the ability of urokinase to mobilize a variety of human and mouse cell lines as well as human primary T lymphocytes. Accordingly, urokinase receptor-dependent signaling, leading to cytoskeletal rearrangements and paxillin re-distribution, does not occur in MCF-7 breast carcinoma cells exposed to 'phosphorylation-like' urokinase. Unlike the wild-type form, di-substituted urokinase is unable to induce the physical association of urokinase receptor with alphavbeta5 vitronectin receptor, which is required for MCF-7 urokinase-dependent cell migration. Finally, the di-substituted variant fails to activate p55fgr, a member of the Src tyrosine kinase family, which mediates cell migration and adhesion of U937 myelomonocytic cells. In conclusion, the finding that specific amino acid substitutions strongly interfere with the ability of urokinase to stimulate cell migration, and the associated intracellular events uncover a novel way to regulate urokinase receptor-dependent signaling.
Collapse
|
30
|
Maffei A, Pozzo GD, Prisco A, Ciullo M, Harris PE, Reed EF, Guardiola J. Polymorphism in the 5' terminal region of the mRNA of HLA-DQA1 gene: identification of four groups of transcripts and their association with polymorphism in the alpha 1 domain. Hum Immunol 1997; 53:167-73. [PMID: 9129975 DOI: 10.1016/s0198-8859(97)83121-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Relative to other loci in the MHC, the HLA-DQ locus exhibits an exceptional degree of polymorphism of both A1 and B1 genes, particularly in the region coding for alpha and beta chains. Diversification of the association between different alpha and beta molecules either in cis or in trans contributes to the structural diversity of the repertoire of cell-surface class II protein's in the population. In addition, structural allelic polymorphisms in the 5' regulatory region of both DQB1 and DQA1 shows several linkage groups with respect to the allelic coding sequence of the respective genes. We describe here the allelic polymorphism in the DQA1 mRNA structure located at the 5' untranslated terminal region. This portion of the mRNA molecule represents, in many genes, a cis-acting regulatory sequence playing a role in the posttranscriptional mechanisms by which gene expression can be modulated. Based on detailed transcriptional analysis, we have been able to define at least four groups of transcripts in DQA1. The mRNA variability was associated with the polymorphism of the second exon of the DQA1 gene, coding for the alpha 1 domain and not with the DNA polymorphism in the 5' regulatory region.
Collapse
Affiliation(s)
- A Maffei
- International Institute of Genetics and Biophysics, CNR, Naples, Italy
| | | | | | | | | | | | | |
Collapse
|